SCHEMBL7108860

SCHEMBL7108860

CCCCc1ccc(Nc2nc(OC)c3nc[nH]c3n2)cc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLA1 P09884 7/20 0.71
HPGD P15428 4/20 0.46
MAPT P10636 3/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
NPC1 O15118 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 3/20 0.41
ALDH1A1 P00352 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
LMNA P02545 1/20 0.41
GAA P10253 1/20 0.41
ALOX12 P18054 1/20 0.41
MAPK1 P28482 1/20 0.41
TP53 P04637 1/20 0.39
XBP1 P17861 1/20 0.39
HTT P42858 1/20 0.39
ATM Q13315 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CDK2 P24941 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10798696 0.83 POLA1 (0.69) POLA1HPGDMAPTMEN1KMT2A
SCHEMBL7108861 0.83 POLA1 (1.00) POLA1HPGDMAPTMEN1KMT2A
SCHEMBL7107628 0.81 POLA1 (0.71) POLA1HPGDMAPTMEN1KMT2A
SCHEMBL17144144 0.76 POLA1 (0.49) POLA1HPGDMAPTMEN1KMT2A
SCHEMBL11012622 0.75 RAB9A (0.55) POLA1HPGDMAPTMEN1KMT2A
SCHEMBL3496869 0.73 POLA1 (0.70) POLA1HPGDMAPTMEN1KMT2A
SCHEMBL10798703 0.71 POLA1 (1.00) POLA1HPGDMAPTMEN1KMT2A
SCHEMBL1264648 0.70 STK17A (0.54) POLA1ALDH1A1LMNATP53HSD17B10
SCHEMBL1266331 0.70 STK17A (0.54) POLA1ALDH1A1LMNATP53HSD17B10
SCHEMBL7107635 0.69 POLA1 (1.00) POLA1HPGDMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1200435-B1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK NOVARTIS AG (CH) 2003-10-01 EP claimed
US-6589950-B1 Treatment of inflammatory or obstructive airways disease for respiratory system disorders NOVARTIS AG (CH) 2003-07-08 US claimed
JP-2003506375-A 2003-02-18 JP claimed
EP-1200435-A1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK Novartis AG (CH) 2002-05-02 EP claimed
WO-2001009134-A1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK NOVARTIS AG (CH) 2001-02-08 WO claimed
EP-1200435-B1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK NOVARTIS AG (CH) 2003-10-01 EP disclosed
US-6589950-B1 Treatment of inflammatory or obstructive airways disease for respiratory system disorders NOVARTIS AG (CH) 2003-07-08 US disclosed
EP-1200435-A1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK Novartis AG (CH) 2002-05-02 EP disclosed
WO-2001009134-A1 PURINE DERIVATIVES INHIBITORS OF TYROSINE PROTEIN KINASE SYK NOVARTIS AG (CH) 2001-02-08 WO disclosed